Urinary neutral endopeptidase in workers exposed to cadmium: Interaction with cigarette smoking

Occupational and Environmental Medicine

Volumn 54, Issue 6, 1997, Pages 432-436

  Nortier, Joëlle ^a   Bernard, Alfred ^c   Roels, Harry ^c   Deschodt Lanckman, Monique ^a   Gueuning, Christiane ^b   Lauwerys, Robert ^c  

^a Lab Pluridisciplinaire Rech E   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Cadmium; Cigarette smoking; Neutral endopeptidase

Indexed keywords

BETA 2 MICROGLOBULIN; CADMIUM; MEMBRANE METALLOENDOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; RETINOL BINDING PROTEIN;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYMURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL INDUSTRY; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEINURIA; SMELTER; URINARY EXCRETION;

EID: 0030858891     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.54.6.432     Document Type: Article

References (28)

1. Ronco P, Pollard H, Galceran M, Delauche M, Schwartz JC, Verroust P. Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody. Lab Invest 1988;58:210-7.
2. Shipp MA, Look AT. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood 1993;82:1052-70.
3. Roques BP, Noble F, Daug V, Fournie-Zaluski M-C, Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993;45:87-146.
4. Schulz WW, Hagler HK, Buja LM, Erdös EG. Ultrastructural localization of angiotensin I- converting enzyme (EC 3.4.15.1) and neutral metalloendo-peptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Lab Invest 1988;59:789-97.
5. Skidgel RA, Schulz WW, Tam LT, Erdös EG. Human renal angiotensin I converting enzyme and neutral endopeptidase. Kidney Int 1987;31:45-8.
6. Deschodt-Lanckman M, Michaux F, de Prez, Abramowicz D, Vanherweghem J-L, Goldman M. Increased serum levels of endopeptidase 24.11 (enkephalinase) in patients with end-stage renal failure. Life Sci 1989;45:133-41.
7. Nortier J, Abramowicz D, Kinnaert P, Deschodt-Lanckman M, Vanherweghem JL. Pathological release of urinary endopeptidase 24.11 early after renal transplantation. Enzyme 1992;46:304-8.
8. Berndt WO. Role of transport in chemically-induced nephrotoxicity. In: Goldberg RS. Mechanisms of injury in renal disease and toxicity. Ann Arbor: CRC Press, 1994:235-46.
9. Bernard AM, Roels HA, Buchet JP, Cardenas A, Lauwerys RR. Cadmium and health: the Belgian experience. In: Nordberg GF, Herber RFM, Alessio L. Cadmium in the human environment: toxicity and carcinogenicity. Lyon: IARC, 1992: 15-33. (IARC Sci Publ No 118.)
10. Lauwerys RR, Bernard AM, Roels HA, Buchet JP. Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem 1994;40:1391-4.
11. Nouwen EJ, de Broe M. Human intestinal versus tissue-nonspecific alkaline phosphatase as complementary urinary markers for the proximal tubule. Kidney Int 1994;46: S43-51.
12. Roels HA, Bernard AM, Cardenas A, Buchet JP, Lauwerys RR, Hotter G, et al. Markers of early renal changes induced by industrial pollutants. III Applications to workers exposed to cadmium. Br J Ind Med 1993;50:37-48.
13. Bernard AM, Thielemans N, Roels HA, Lauwerys RR. Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med 1995;52: 177-80.
14. Staessen JA, Lauwerys RR, Ide G, Roels HA, Vincke G, Amery A. Renal function and historical environmental cadmium pollution from zinc smelters. Lancet 1994;343: 1523-7.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
16. Tucker SM, Boyd PJR, Thompson AE, Price RG Automatic assay of N-acetyl-β-D-glucosaminidase in normal and pathological human urine. Clin Chim Acta 1975;62:333-9.
17. Kritz W, Samaan GJ, Leberre C, Demelier JF, Biou D. Semi-automated fluorimetric assay for total and B N-acetyl-β-D-glucosaminidase: analytical investigation. J Clin Lab Analysis 1991;5:1-2.
18. Bernard AM, Lauwerys RR. Continuous flow system for the automation of latex immunoassay by particle counting. Clin Chem 1983;29:1007-11.
19. Roels HA, Lauwerys RR, Buchet JP, Bernard AM, Vos A, Overstyns M. Health significance of cadmium-induced renal dysfunction, a five-year follow-up. Br J Ind Med 1989;46:755-64.
20. American Conference of Governmental Industrial Hygienists. Cadmium, methylisobutylketone and trichloroethylene. Appl Occup Environ Hyg 1991;6:703-10.
21. Fels LM, Bundschuh I, Gwinner W, Jung K, Pergande M, Graubaum HJ, et al. Early urinary markers of target nephron segments as studied in cadmium toxicity. Kidney Int 1994;46:S81-8.
22. 2+) disrupts intercellular junctions and actin filaments in LLC-PK1 cells. Toxicol Appl Pharmacol 1991;107:81-97.
23. Kimura O, Endo T, Sakata M. Comparison of cadmium uptakes from apical and basolateral membranes of LLC-PK1 cells. Toxicol Appl Pharmacol 1996;137:301-6.
24. Kellerman PS, Clark RAF, Hoilien CA, Linas SL, Molitoris BA. Role of microfilaments in maintenance of proximal tubule structural and functional integrity. Am J Physiol 1990;259:F279-85.
25. Reed DJ. Glutathione: toxicological implications. Ann Rev Pharmacol Toxicol 1990;30:603-31.
26. Splittgerber AG, Tappel AL. Inhibition of glutathione peroxidase by cadmium and other metal ions. Arch Biochem Biophys 1979;197:534-42.
27. Sidhu M, Sharma M, Bhatia M, Awasthi YC, Nath R. Effects of chronic cadmium exposure on glutathione S-transferase and glutathione peroxidase activities in rhesus monkey: the role of selenium. Toxicology 1993;83: 203-13.
28. Prozialek WC, Lamar P. Effects of glutathione depletion on the cytotoxic actions of cadmium in LLO-PK1 cells. Toxicol Appl Pharmacol 1995;34:285-95.